QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.019612v1 70/3/986    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sim-Selley, L. J. Articles by Selley, D. E. Search for Related Content PubMed PubMed Citation Articles by Sim-Selley, L. J. Articles by Selley, D. E.

Prolonged Recovery Rate of CB₁ Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration

Department of Pharmacology and Toxicology and Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia

Long-term cannabinoid administration produces region-dependent CB₁ receptor desensitization and down-regulation. This study examined the time course for normalization of CB₁ receptors and G-protein activation using ³H-labeled N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboximide hydrochloride (SR141716A) and guanosine 5'-O-(3-[³⁵S]thio)triphosphate ([³⁵S]GTPS binding), respectively, in hippocampus and striatum/globus pallidus (GP). Mice were treated with escalating doses of ⁹-tetrahydrocannabinol (⁹-THC) or R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo-[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) for 15 days, and tissue was collected 1, 3, 7, or 14 days after final injection. [³H]SR141716A and WIN55,212-2-stimulated [³⁵S]GTPS binding were decreased in both regions 1 day after treatment. WIN55,212-2-stimulated G-protein activation in striatum/GP returned to control level at 3 days after cessation of treatment with either drug but did not return to control level in hippocampus until 14 days. CB₁ receptor binding did not recover to control levels until day 7 or 14 after treatment in striatum/GP and hippocampus, respectively. The mechanism of CB₁ binding site down-regulation was investigated after long-term ⁹-THC treatment. Analysis of CB₁ receptor mRNA in hippocampus and striatum/GP showed that transcriptional regulation could not explain prolonged recovery rates from CB₁ receptor down-regulation. In contrast, CB₁ receptor protein, as determined by immunoblot analysis, matched the down-regulation and recovery rates of CB₁ receptor binding sites relatively closely. These data demonstrate that cannabinoid-induced decreases in CB₁ receptor function persist for relatively long time periods after cessation of long-term drug treatment and that CB₁ receptor signaling recovers more quickly in striatum/GP than hippocampus. Moreover, down-regulation of CB₁ receptor binding sites does not seem to result mainly from transcriptional regulation, suggesting that adaptive regulation of CB₁ receptors in brain primarily occurs at the protein level.

Address correspondence to: Dr. Dana E. Selley, Department of Pharmacology and Toxicology, Box 980524, 1112 East Clay Street, Richmond, VA 23298. E-mail: deselley{at}vcu.edu

This article has been cited by other articles:

				D. L. McKinney, M. P. Cassidy, L. M. Collier, B. R. Martin, J. L. Wiley, D. E. Selley, and L. J. Sim-Selley Dose-Related Differences in the Regional Pattern of Cannabinoid Receptor Adaptation and in Vivo Tolerance Development to {Delta}9-Tetrahydrocannabinol J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 664 - 673. [Abstract] [Full Text] [PDF]

				L. Martini, M. Waldhoer, M. Pusch, V. Kharazia, J. Fong, J. H. Lee, C. Freissmuth, and J. L. Whistler Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1 FASEB J, March 1, 2007; 21(3): 802 - 811. [Abstract] [Full Text] [PDF]